Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

U.S. university and Novartis launch exclusive licensing agreement

Aug. 21, 2012

Investigational BCR-ABL inhibitor enters new phase I/II trial in Japan

Aug. 21, 2012

Proximagen discloses novel PAR2 receptor antagonists

Aug. 21, 2012

Dainippon Sumitomo Pharma establishes new oncology institute

Aug. 21, 2012

U.K. alliance set to launch AZD-8931 combination trial

Aug. 20, 2012

Lenvatinib obtains orphan drug status

Aug. 20, 2012

Enrollment complete in two Reolysin studies

Aug. 20, 2012

Novel candidate cancer gene therapies developed in U.S.

Aug. 20, 2012

Promising results reported for SNS01-T in multiple myeloma study

Aug. 17, 2012

CRT licenses preclinical FAK inhibitor programs

Aug. 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...